|
NIH - Focal Cognitive Deficits in CNS Disorders (R01) |
|
|
|
|
http://grants.nih.gov/grants/guide/pa-files/pa-07-033.html
The purpose of this FOA is to advance the study of focal, or specific and limited, cognitive deficits
experienced by persons with non-dementing CNS disorders and the secondary
effects of these cognitive deficits on their health and quality of life (QoL).
This FOA also promotes the development
of evidence and theory-based clinical interventions
and therapeutics for cognitive impairment in persons with non-dementing CNS
disorders. A goal of this FOA is to
enhance cross- and inter-disciplinary biobehavioral cognitive research.
For the purposes of this FOA, the
following general distinction between dementing and non-dementing disorders
should be used:
- Dementing disorders (e.g., Alzheimer disease,
frontotemporal dementia, prion diseases, and many forms of MCI [minimal
cognitive impairment]), inevitably cause global
cognitive deficits and are generally thought to be progressive. Dementing
disorders are thought to move affected persons through a continuum from normal
cognition to generalized dementia, albeit sometimes in a slowly declining
fashion.
- Non-dementing CNS disorders
(e.g., epilepsy, multiple sclerosis, cerebral palsy, or ALS), the focus
of this FOA,
affect one or a limited number of focal or confined cognitive functions
while leaving others intact, and may be non- or slowly- progressing.
Non-dementing CNS disorders rarely cause global dementia, or do so only
in the minority of cases, typically in the latest stages of the
disease. The cognitive deficits seen in non-dementing CNS disorders
may be subtle or marked, singular or clustered. They may affect a
range of functions, such as decision-making, psychosocial behaviors,
participation in health-seeking and health-maintaining behaviors, or
occupational performance. Implicit in the definition of non-dementing
CNS disorders is the existence of circumscribed targets for
intervention, as well as the presence of sufficient neurofunctional
reserve to make possible engagement in and benefit from treatment.
|